Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T Cells
100%
Tumor Antigen
100%
Cancer Therapy
100%
Human Tumors
100%
Cytotoxic T Lymphocytes
40%
Tumor
20%
Tumor-specific
20%
Autoimmune Disease
20%
Tumor Cells
20%
Complementary DNA (cDNA)
20%
Upstream Open Reading Frame (uORF)
20%
Adoptive Transfer
20%
Tyrosinase-related protein-1
20%
Tumor-infiltrating Lymphocytes
20%
Patients with Cancer
20%
Human Cancer
20%
Therapeutic Strategies
20%
Interleukin-2
20%
Antitumor Activity
20%
Cancer Antigen
20%
Expression System
20%
Catenin
20%
Cyclin-dependent Kinase 4 (CDK4)
20%
Tumor Rejection
20%
Biochemical Approaches
20%
Self-protein
20%
Systems Approach
20%
Potential Clinical Applications
20%
Medicine and Dentistry
T Lymphocyte
100%
Tumor Antigen
100%
Cancer Therapy
100%
Malignant Neoplasm
33%
Cytotoxic T-Cell
33%
Neoplasm
16%
Specific Tumor
16%
Autoimmune Disease
16%
Tumor Cell
16%
Complementary DNA
16%
Adoptive Transfer
16%
Interleukin 2
16%
Antineoplastic Activity
16%
Open Reading Frame
16%
Catenin
16%
Tumor Infiltrating Lymphocyte
16%
Tumor Rejection Antigen
16%
Gene Expression System
16%
Cyclin-Dependent Kinase 4
16%
Tyrosinase Related Protein 1
16%
Immunology and Microbiology
T Cell
100%
Tumor Antigen
100%
Cytotoxic T Cell
33%
Open Reading Frame
16%
Tumor-Infiltrating Lymphocytes
16%
Autoimmune Disease
16%
Interleukin 2
16%
Tumor Cell
16%
Antineoplastic Activity
16%
Gene Expression System
16%
Cycline
16%
Tumor Rejection Antigen
16%
Self-Protein
16%
Catenin
16%